Stay updated on Durvalumab Combinations in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.

Latest updates to the Durvalumab Combinations in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page’s interface/version footer was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a site software release rather than a change to the underlying clinical trial record history.SummaryDifference0.1%

- Check25 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the study record history.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed from the record history.SummaryDifference0.1%

- Check61 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 in the history list.SummaryDifference0.1%

- Check89 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the earlier funding-lapse notice (v3.4.1).SummaryDifference0.5%

- Check96 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Durvalumab Combinations in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combinations in NSCLC Clinical Trial page.